Mycoplasmas are the smallest free-living organisms. These organisms lack cell wall, making them highly unique prokaryotes. This also prevents them from being affected by penicillin and cephalosporin. Mycoplasmas are connected with mucosal surfaces, which are present in the urogenital and respiratory tracts. These organisms enter the submucosa, when in the case of instruments entering the body’s bloodstream or organs.
Innovation
Meridian Bioscience, Inc., is an Ohio-based international producer and distributor of a number of diagnostic test kits. The company launched a molecular test to identify mycoplasma pneumonia. The “illumigene Mycoplasma Direct” assay comes equipped with an easy to use procedure and simple features. This kit can provide ultimate results under an hour. By making the test simple, the company anticipates to provide its users with a better diagnostic tool, which will improve patient care and provide the patient with the require targeted detection, which is of utmost importance for the proper treatment.
“M.pneumoniae” or “Walking pneumonia” is related to almost 40% of the community-acquired pneumonias. This testing kit (illumigene Mycoplasma Direct) is effective immediately by magnifying the specific DNA for the detection of active Mycoplasma pneumonia infection. This simple procedure takes less than 2 minutes as it requires a throat swabs to provide the user with highly sensitive results. Additionally, the simplicity of the technological allows it cost efficient and to leave a smaller footprint. It also enables early diagnosis to prevent an outbreak.
Market Overview
According to a new study by Grand View Research, Inc; the Mycoplasma testing market is anticipated to reach USD 1.4 billion by 2025. Growing healthcare spending level and research activities can impel the growth of the market over the coming years.
Rivals
InvivoGen.; Merck KGaA; Lonza Group Ltd.; PromoCell GmbH; and Thermo Fisher Scientific; are some of the key players of the Mycoplasma testing market. The players participate in launching new product, geographical expansions, and mergers & acquisitions as their key strategies to expand their business globally.
In-Depth research report on Mycoplasma testing market:
No comments:
Post a Comment